Lion Licenses SRS to Genomics Collaborative | GenomeWeb

NEW YORK, Aug. 30 – Lion Bioscience of Heidelberg, Germany, said Thursday that it had licensed its SRS platform to Genomics Collaborative of Cambridge, Mass.

The companies said the SRS platform would allow users to access GCI's databases of patient clinical and sample information as well as public biological data sources via one portal. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.